John Tilton

(Mr. John Tilton)

Currently holds a position at Biohaven Pharmaceutical Holding Company Ltd

Positions
Position Company Period
Chief Commercial Officer, Rare and Orphan Diseases Biohaven Pharmaceutical Holding Company Ltd April 1, 2019 -
Chief Commercial Officer Biohaven Pharmaceutical Holding Company Ltd April 1, 2016 - April 1, 2019
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2020-06-12 2020-06-10
PS Planned sale
2,467 -76.2%
69.40
171,202 USD 		2,467 -76.2% 69.40 171,202 USD
2020-06-12 2020-06-10
PS Planned sale
5,331 -62.2%
68.57
365,528 USD 		5,331 -62.2% 68.57 365,528 USD
2020-06-12 2020-06-10
PS Planned sale
22,838 -72.7%
67.53
1,542,234 USD 		22,838 -72.7% 67.53 1,542,234 USD
2020-06-12 2020-06-10
PS Planned sale
21,364 -40.5%
66.70
1,425,036 USD 		21,364 -40.5% 66.70 1,425,036 USD
2019-03-14 2019-03-12
PS Planned sale
10,000 -100.0%
50.11
501,100 USD 		10,000 -100.0% 50.11 501,100 USD
2019-01-14 2019-01-10
PS Planned sale
10,500 -100.0%
37.67
395,535 USD 		10,500 -100.0% 37.67 395,535 USD